Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib

Published:2019-07 Issue:27 Volume:294 Page:10428-10437
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Terzyan Simon S.,Shen Tao,Liu Xuan,Huang Qingling,Teng Peng,Zhou Mi,Hilberg Frank,Cai Jianfeng,Mooers Blaine H.M.^ORCID,Wu Jie^ORCID

Funder

HHS | NIH | National Cancer Institute (NCI))

HHS | NIH | National Institute of General Medical Sciences (NIGMS))

U.S. Department of Energy (DOE))

HHS | NIH | National Institute on Aging (NIA))

Presbyterian Health Foundation)

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference41 articles.

1. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update;Wells;J. Clin. Endocrinol. Metab,2013

2. Novel targets in non-small cell lung cancer: ROS1 and RET fusions;Gainor;Oncologist,2013

3. RET aberrations in diverse cancers: next-generation sequencing of 4,871 patients;Kato;Clin. Cancer Res,2017

4. Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial;Yoh;Lancet Respir. Med,2017

5. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial;Wells;J. Clin. Oncol,2012

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medullary Thyroid Cancer: Molecular Drivers and Immune Cellular Milieu of the Tumour Microenvironment—Implications for Systemic Treatment;Cancers;2024-06-22

2. Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations;Journal of Medicinal Chemistry;2024-03-14

3. Generating Potential RET-Specific Inhibitors Using a Novel LSTM Encoder–Decoder Model;International Journal of Molecular Sciences;2024-02-17

4. To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors;Current Topics in Medicinal Chemistry;2023-12

5. Idiopathic pulmonary fibrosis: Pathophysiology, cellular signaling, diagnostic and therapeutic approaches;Medicine in Drug Discovery;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3